HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Dilek Erdem Selected Research
Dilek Erdem Research Topics
Disease
8
Neoplasms (Cancer)
02/2022 - 12/2008
2
Stomach Neoplasms (Stomach Cancer)
05/2022 - 03/2018
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 01/2022
2
Breast Neoplasms (Breast Cancer)
02/2022 - 12/2008
2
Neoplasm Metastasis (Metastasis)
01/2022 - 08/2021
2
Carcinoma (Carcinomatosis)
09/2021 - 08/2021
2
Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 03/2015
2
Nausea
03/2015 - 07/2012
2
Vomiting
03/2015 - 07/2012
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2022
1
Adenocarcinoma
05/2022
1
Phobic Disorders (Phobia)
02/2022
1
COVID-19
02/2022
1
Brain Neoplasms (Brain Tumor)
01/2022
1
Urinary Bladder Neoplasms (Bladder Cancer)
08/2021
1
Neutropenia
01/2019
1
Diarrhea
01/2019
1
Exanthema (Rash)
01/2019
1
Infections
01/2019
1
Hepatitis B
06/2016
1
Hypoxia (Hypoxemia)
10/2015
1
Pulmonary Embolism
10/2015
1
Thrombosis (Thrombus)
10/2015
1
Peritoneal Neoplasms
01/2015
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2014
1
Lymphopenia (Lymphocytopenia)
12/2014
1
Lymphatic Metastasis
12/2008
1
Angle Class I Malocclusion (Angle Class I)
10/2007
1
Angle Class II Malocclusion (Angle Class II)
10/2007
Drug/Important Bio-Agent (IBA)
3
atezolizumab
IBA
12/2022 - 08/2021
2
Tyrosine Kinase Inhibitors
IBA
04/2022 - 01/2022
2
Epidermal Growth Factor (EGF)
IBA
02/2022 - 10/2015
2
Platinum
IBA
09/2021 - 08/2021
1
Afatinib
IBA
04/2022
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
04/2022
1
exemestane (Aromasin)
FDA Link
02/2022
1
Everolimus
FDA Link
02/2022
1
COVID-19 Vaccines
IBA
02/2022
1
Hormones (Hormone)
IBA
02/2022
1
Vaccines
IBA
02/2022
1
N-acetoacetyl-N-deacetylcolchicine
IBA
01/2022
1
Biomarkers (Surrogate Marker)
IBA
01/2022
1
alectinib
IBA
01/2022
1
Hemoglobins (Hemoglobin)
IBA
08/2021
1
Creatinine
IBA
08/2021
1
Panitumumab (Vectibix)
FDA Link
01/2019
1
Bevacizumab (Avastin)
FDA Link
01/2019
1
Cetuximab (Erbitux)
FDA Link
01/2019
1
taxane
IBA
03/2018
1
Anti-Idiotypic Antibodies
IBA
06/2016
1
Rituximab (Mabthera)
FDA Link
06/2016
1
Hepatitis B Surface Antigens (HBsAg)
FDA Link
06/2016
1
Biological Products
IBA
10/2015
1
Protein Sorting Signals (Signal Peptide)
IBA
10/2015
1
fibrin fragment D (D-dimer)
IBA
10/2015
1
Monoclonal Antibodies
IBA
03/2015
1
Immunoglobulin E (IgE)
IBA
12/2014
1
Interleukin-4 (Interleukin 4)
IBA
12/2014
1
Interleukin-10 (Interleukin 10)
IBA
12/2014
1
Palonosetron (Aloxi)
FDA Link
07/2012
1
Steroid Receptors (Steroid Receptor)
IBA
12/2008
1
Factor VIII (Coagulation Factor VIII)
IBA
12/2008
1
Hemostatics (Antihemorrhagics)
IBA
12/2008
1
Factor IX (Coagulation Factor IX)
FDA Link
Generic
12/2008
Therapy/Procedure
8
Drug Therapy (Chemotherapy)
12/2022 - 07/2012
4
Therapeutics
01/2019 - 03/2015
1
Neoadjuvant Therapy
05/2022
1
Immunotherapy
08/2021
1
Adjuvant Chemotherapy
03/2015
1
Cytoreduction Surgical Procedures
01/2015
1
Operative Time
01/2015
1
Hyperthermic Intraperitoneal Chemotherapy
01/2015
1
Fixed Orthodontic Appliances
10/2007